A preliminary report on the usefulness of monoclonal antibodies to CA 15-3 and MCA in the detection of micrometastases in axillary lymph nodes draining primary breast carcinoma
Authors:
- H.F. GivenHGH.F. Given
- P.G. HorganPHP.G. Horgan
- S. EnglandSES. England
- J. CallaghanJCJ. Callaghan
- 31 March 1992
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 28 (2-3) , 658-660
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- CA15-3: Its relationship to clinical stage and progression to metastatic disease in breast cancerBritish Journal of Surgery, 1989
- Monoclonal antibody DF3 correlates with tumor differentiation and hormone receptor status in breast cancer patientsBreast Cancer Research and Treatment, 1985
- The immunocytochemical detection of axillary micrometastases in breast cancerBritish Journal of Cancer, 1984
- Differential Reactivity of a Novel Monoclonal Antibody (DF3) with Human Malignant versus Benign Breast TumorsHybridoma, 1984
- The cancer research campaign (King's/Cambridge trial for early breast cancer: Clinico-pathological aspectsBritish Journal of Cancer, 1982
- The use of antisera to epithelial membrane antigen in detecting micrometastases in histological sectionsBritish Journal of Cancer, 1980
- Identification of breast cancer patients with high risk of early recurrence after radical mastectomy. II. Clinical and pathological correlationsCancer, 1978
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and designBritish Journal of Cancer, 1976
- Significance of occult metastases.A study of breast cancerCancer, 1961